Recent studies have also identified mutations in diacylglycerol kinase-ε (DGKE), thrombomodulin (THBD, CD141) in thrombotic microangiopathies (TMAs) including aHUS [8–13]. This evidence concerns the gene THBD and Genetic thrombotic microangiopathy.